Figure 5From: HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin AWestern blot analysis of Cakiresexposed to 1 mM VPA for one (1 wk) or two weeks (2 wks) showing cell cycle regulating proteins and target molecules of mTOR- (A) and HDAC-inhibitors (B). VPA untreated cells served as controls. β-actin served as the internal control. The figure shows one representative from three separate experiments.Back to article page